Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Decrease corneal hysteresis in steroid-induced ocular hypertension: a case report.

Molinari JF.

Mil Med. 2013 Jul;178(7):e862-4. doi: 10.7205/MILMED-D-12-00492.

PMID:
23820367
2.

Corneal biomechanics in steroid induced ocular hypertension.

Yülek F, Gerçeker S, Akçay E, Saraç Ö, Çağıl N.

Cont Lens Anterior Eye. 2015 Jun;38(3):181-4. doi: 10.1016/j.clae.2015.01.011. Epub 2015 Feb 25.

PMID:
25731817
3.

Dexamethasone-netilmicin: a new ophthalmic steroid-antibiotic combination. Efficacy and safety after cataract surgery.

Russo S, Papa V, Di Bella A, Favero A, Radulescu C, Gafencu O, Carstocea B, Milazzo G.

Eye (Lond). 2007 Jan;21(1):58-64. Epub 2005 Nov 4.

PMID:
16273088
4.

Effect of topical prostaglandin analogues on corneal hysteresis.

Bolívar G, Sánchez-Barahona C, Teus M, Castejón MA, Paz-Moreno-Arrones J, Gutiérrez-Ortiz C, Mikropoulos DG.

Acta Ophthalmol. 2015 Sep;93(6):e495-8. doi: 10.1111/aos.12689. Epub 2015 Feb 26.

5.

[The glaucoma pharmacological treatment and biomechanical properties of the cornea].

Liehneová I, Karlovská S.

Cesk Slov Oftalmol. 2014 Oct;70(5):167-76. Czech.

PMID:
25640039
6.

Diagnosis of steroid-induced elevated intraocular pressure and associated lamellar keratitis after laser in situ keratomileusis using optical coherence tomography.

Levinger E, Slomovic A, Bahar I, Slomovic AR.

J Cataract Refract Surg. 2009 Feb;35(2):386-8. doi: 10.1016/j.jcrs.2008.08.044.

PMID:
19185259
8.

Outcome of Ocular Steroid Hypertensive Response in Children.

Kaur S, Dhiman I, Kaushik S, Raj S, Pandav SS.

J Glaucoma. 2016 Apr;25(4):343-7. doi: 10.1097/IJG.0000000000000209.

PMID:
25651206
9.

Incidence of steroid induced-ocular hypertension in postoperative pterygium excision.

Makornwattana M, Suphachearaphan W.

J Med Assoc Thai. 2015 Mar;98 Suppl 2:S151-7.

PMID:
26211117
10.

Ocular hypertensive response to topical dexamethasone ointment in children.

Lee YJ, Park CY, Woo KI.

Korean J Ophthalmol. 2006 Sep;20(3):166-70.

11.
12.

Evaluation of corneal biomechanical properties with the Reichert Ocular Response Analyzer.

Detry-Morel M, Jamart J, Pourjavan S.

Eur J Ophthalmol. 2011 Mar-Apr;21(2):138-48.

PMID:
20853262
13.

Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.

Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ.

Curr Eye Res. 1995 Mar;14(3):229-34.

PMID:
7796606
14.

Intraocular pressure-induced interlamellar keratitis after LASIK surgery.

Davidson RS, Brandt JD, Mannis MJ.

J Glaucoma. 2003 Feb;12(1):23-6.

PMID:
12567106
15.

Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.

Razali N, Agarwal R, Agarwal P, Kapitonova MY, Kannan Kutty M, Smirnov A, Salmah Bakar N, Ismail NM.

Eur J Pharmacol. 2015 Feb 15;749:73-80. doi: 10.1016/j.ejphar.2014.11.029. Epub 2014 Dec 4.

PMID:
25481859
16.

[Total refractive regression post-LASIK: case report].

Gus PI, Matos GH, Bayer MC.

Arq Bras Oftalmol. 2005 May-Jun;68(3):393-5. Epub 2005 Jul 26. Portuguese.

17.

Surgical intervention of steroid-induced ocular hypertension from Ozurdex.

Sejpal P, Scott-Weideman J.

Optom Vis Sci. 2013 Jan;90(1):e24-30. doi: 10.1097/OPX.0b013e318279eba0.

PMID:
23241827
18.

Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.

Fingert JH, Clark AF, Craig JE, Alward WL, Snibson GR, McLaughlin M, Tuttle L, Mackey DA, Sheffield VC, Stone EM.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):145-52.

PMID:
11133859
19.

Steroid-induced interface fluid syndrome after LASIK.

Moya Calleja T, Iribarne Ferrer Y, Sanz Jorge A, Sedó Fernandez S.

J Refract Surg. 2009 Feb;25(2):235-9.

PMID:
19241776
20.

Efficacy and safety of netilmycin/dexamethasone preservative-free and tobramycin/dexamethasone-preserved fixed combination in patients after cataract surgery.

Pianini V, Passani A, Rossi GC, Passani F.

J Ocul Pharmacol Ther. 2010 Dec;26(6):617-21. doi: 10.1089/jop.2010.0050. Epub 2010 Oct 29.

PMID:
21034176

Supplemental Content

Support Center